Clinical Trials Logo

Stomach Diseases clinical trials

View clinical trials related to Stomach Diseases.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06213948 Recruiting - Healthy Clinical Trials

Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators

Start date: August 1, 2021
Phase: Phase 1
Study type: Interventional

The goal of this study is to investigate the mechanisms of impaired gastric accommodation and emptying, dysfunctional duodenum, and micro-inflammation using novel imaging techniques of SPECT/CT, gastric emptying scintigraphy, MRI, high-resolution manometry, and inflammatory biomarkers, as well as to validate these mechanisms using a therapeutic trial of neuromodulator (mirtazapine) in functional dyspepsia (FD) and health. The main objective[s] it aims to answer are: - to investigate impaired gastric accommodation through SPECT/CT imaging and high-resolution manometry findings of the stomach fundus. - to investigate impaired gastric emptying through gastric emptying scintigraphy - to investigate for a dysfunctional duodenum through MRI imaging of the duodenum. - to investigate micro-inflammation through SPECT/CT standard uptake value (SUV), inflammatory biomarkers (eosinophils, mast cells, IL-6, IL-10) and mucosal barrier marker (E-cadherin). - to investigate if a therapeutic trial of a neuromodulator agent, mirtazapine, ameliorates symptoms of FD through improvement in impaired gastric accommodation. For objectives 1-4, FD patients and healthy volunteers will be consecutively recruited, and all will undergo SPECT/CT, MRI, high-resolution manometry and biomarkers, and data acquired from these tests will be analyzed. For objective 5, the enrolled participants who did all baseline tests/markers are given mirtazapine for four weeks, and all tests/markers, except biomarkers and MRI, are repeated at the end of the trial

NCT ID: NCT05249933 Recruiting - Capsule Endoscopy Clinical Trials

Pronase Granules in Gastric Cleaning

Start date: February 24, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Magnetically controlled capsule endoscopy (MCE) is now widely used all over the world. However, the standard gastric preparation method by dimethicone we used clinically still has mucus at the bottom of the stomach. In this study, we aimed to determine whether pronase granules is helpful to improve the cleanliness of gastric mucosa in MCE.

NCT ID: NCT05069233 Recruiting - Stomach Diseases Clinical Trials

Magnetically Controlled Capsule Endoscopy in Visualization of the UGI and Small Intestine

Start date: September 27, 2021
Phase:
Study type: Observational

In this study, we retrospectively analyzed the videos of combined upper digestive tract and small intestine examination under MCE, so as to clarify the feasibility and diagnostic efficacy of MCE in one-time examination of the upper gastrointestinal and small intestinal mucosa.

NCT ID: NCT04068480 Recruiting - Esophageal Diseases Clinical Trials

Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy

MACEOES
Start date: November 15, 2017
Phase:
Study type: Observational

Magnetically controlled capsule endoscopy (MCCE) is an outstanding opportunity for the painless endoscopic screening of the esophagus and stomach before small bowel examiantion. Further improvement in patients positioning might increase the esophageal transit time of the capsule endoscope and could improve the sensitivity and specificity of the esophageal MCCE investigation. Our present study aimed to compare the visualization of the esophagus (especially the Z-line) with different capsule swallowing protocols.

NCT ID: NCT03267355 Recruiting - Pancreatic Diseases Clinical Trials

Indications and Outcomes of Endoscopic Ultrasound in Tanta

Start date: January 2016
Phase: N/A
Study type: Interventional

The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital.

NCT ID: NCT02846155 Recruiting - Stomach Diseases Clinical Trials

Gastric Preparation of Magnetic-controlled Capsule Endoscopy

Start date: May 2016
Phase: Phase 2
Study type: Interventional

By using three different Gastric Preparation of Magnetic-controlled Capsule Endoscopy, the investigators hope to find out the optimal gastric preparation plan.

NCT ID: NCT02179775 Recruiting - Migraine Headache Clinical Trials

Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks

Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Quince Oxymel is effective in the prevention of Migraine attacks in patients with simultaneous upper gastrointestinal dysfunction.

NCT ID: NCT01741363 Recruiting - Colorectal Cancer Clinical Trials

Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing

Start date: July 2012
Phase: N/A
Study type: Interventional

1. The abundant results from this trial will be helpful for assessing the feasibility of increasing stool sampling and shortening screening interval in population setting for lower and upper gastrointestinal tract lesions, their long-term effects, and the respective cost-effectiveness. 2. The study will evaluate the value of population-based screen and treatment for H. pylori infection when the HPSA is combined with the FIT.